Tolga Tanguler - 02 Mar 2026 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Tolga Tanguler
Issuer symbol
ALNY
Transactions as of
02 Mar 2026
Net transactions value
-$523,584
Form type
4
Filing time
04 Mar 2026, 19:30:06 UTC
Previous filing
02 Mar 2026
Next filing
06 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tanguler Tolga EVP, Chief Commercial Officer 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Tolga Tanguler 04 Mar 2026 0001849458

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award +4,769 +14% $0.000000* 38,204 02 Mar 2026 Direct F1
transaction ALNY Common Stock Sale $15,210 -47 -0.12% $323.62 38,157 02 Mar 2026 Direct F2, F3
transaction ALNY Common Stock Sale $29,218 -90 -0.24% $324.65 38,067 02 Mar 2026 Direct F2, F4
transaction ALNY Common Stock Sale $84,013 -258 -0.68% $325.63 37,809 02 Mar 2026 Direct F2, F5
transaction ALNY Common Stock Sale $128,110 -392 -1% $326.81 37,417 02 Mar 2026 Direct F2, F6
transaction ALNY Common Stock Sale $107,803 -329 -0.88% $327.67 37,088 02 Mar 2026 Direct F2, F7
transaction ALNY Common Stock Sale $32,871 -100 -0.27% $328.71 36,988 02 Mar 2026 Direct F2, F8
transaction ALNY Common Stock Sale $56,051 -170 -0.46% $329.71 36,818 02 Mar 2026 Direct F2, F9
transaction ALNY Common Stock Sale $26,799 -81 -0.22% $330.85 36,737 02 Mar 2026 Direct F2, F10
transaction ALNY Common Stock Sale $31,201 -94 -0.26% $331.93 36,643 02 Mar 2026 Direct F2, F11
transaction ALNY Common Stock Sale $12,308 -37 -0.1% $332.64 36,606 02 Mar 2026 Direct F2, F12

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award +10,480 $0.000000* 10,480 02 Mar 2026 Common Stock 10,480 $325.07 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
F2 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $323.16 to $324.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $324.20 to $325.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $325.21 to $326.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $326.23 to $327.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $327.24 to $328.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $328.28 to $329.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $329.29 to $330.29. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $330.30 to $331.30. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $331.32 to $332.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $332.34 to $332.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.